27.4000.51% ( -0.140 )
Closed: Nov 20, 16:00:00 (EDT)Forecast
Forecast & Rating28 analysts currently cover Pfizer, with about 35.7% giving a positive rating — meaning they expect the stock to rise. The average price target is $30.22, about 10.3% upside from the current price of $27.40. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 23.6% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Pfizer's outlook. Data as of Nov 21, 2026; for reference only and not investment advice.
Nov 20, 2026Price forecast
$30.2210.30%
Forecast & RatingBuy
28analysts
- Strong buy28.57%
- Buy7.14%
- Hold57.14%
- Sell3.57%
- Strong sell3.57%
- Strong buy
- 8
- Buy
- 2
- Hold
- 16
- Sell
- 1
- Strong sell
- 1
Target price forecast
Forecast dateNov 16, 2026
Forecast met29.6%
Stock price$27.40
Avg. target$30.2
High target$37
Low target$25
- Avg. target
- $30.2
- High target
- $37
- Low target
- $25
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.
